Skip to main content
Clinical Trials/NCT00602095
NCT00602095CompletedPhase 3

A Randomised Comparison Between Intravaginal Dinoprostone Intravaginal Misoprostol and Transcervical Balloon Catheter for Labour Induction

Karolinska University Hospital0 sites592 target enrollmentStarted: December 2004Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
592
Primary Endpoint
Time from treatment start to delivery

Study Overview

Brief Summary

This is a randomised study aimed at comparing the currently most frequently used prostaglandin dinoprostone to two other methods, the cheaper and perhaps more effective prostaglandin misoprostol and a transcervical catheter. 592 women were recruited and randomised to one of the three methods. The main outcome measures were time to delivery, rate of instrumental deliveries and maternal neonatal outcome. Our hypothesis was that misoprostol would be superior to the other methods.

The main finding of our trial was that the catheter showed the shortest induction to delivery interval. There were no differences between the two other prostaglandins. No differences in maternal and neonatal outcome was found

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Full term singleton pregnancy with vertex presentation and with an indication for labour induction.
  • Absence of active labour
  • Bishop score ≤
  • Normal CTG registration

Exclusion Criteria

  • Previous cesarean section
  • signs of infection
  • immediate need for delivery
  • any contraindication for vaginal delivery

Arms & Interventions

1

Experimental

Labour induction with misoprostol

Intervention: misoprostol (Drug)

2

Active Comparator

Labour induction with dinoprostone

Intervention: dinoprostone (Drug)

3

Experimental

Labour induction with bard

Intervention: Bard Catheter (balloon catheter) (Device)

Outcomes

Primary Outcomes

Time from treatment start to delivery

Time Frame: At delivery

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Karolinska University Hospital
Sponsor Class
Other

Similar Trials